A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.
Clinical trial NCT07199257 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07199257
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2027-05-15
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.